drugset / Trial / NCT02442817
Linagliptin and Mesenchymal Stem Cells: A Pilot Study
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of the present study is to gather pilot data on the effects of linagliptin on the concentration of the long and short forms of SDF1-α (stromal cell-derived factor alpha) in humans, and to demonstrate the feasibility of such a study in patients with psychosis in our setting.
Timeline
- Start
- 2015-03-02
- Primary completion
- 2018-03-02
- Completion
- 2018-03-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Linagliptin | Small molecule | 5 mg | Oral |